February 21, 2017 / 7:34 AM / 5 months ago

BRIEF-Neurovive Q4 pretax loss doubles yr/yr

1 Min Read

Feb 21 (Reuters) - Neurovive Pharmaceutical AB

* Q4 loss before tax was SEK 14.6 million (7.4) Source text for Eikon: Further comOpany coverage: (Stockholm Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below